6Y6-11082-60626
4 vaccinations
7 coded responses
38 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 546 / WI
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Pfizer-BioNTech
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy, Unevaluable event — Feeling: GoodFree text: Single shotty cervical node on same side as injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Single cervical node on same side as injection (1cm)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-15
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: SARS-CoV-2 test negative, Viral upper respiratory tract infection — Feeling: GoodFree text: Covid negative viral URIMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, DiarrheaAdult check-in
- 2021-09-30
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild lymphadenopathy in ipsilateral Scilla, no different from previous Covid vaccine injectionsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild ipsilateral axillary adenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Previously described adeopathy resolvingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-12-28
- 2022-03-31
-
2022-04-15
Dose 4 — Moderna
- 2022-05-15
- 2022-05-20
-
2022-05-27
Survey response — day 42, dose 4MedDRA: COVID-19, Nasal congestion, Respiratory symptom — Feeling: Good · Be unable to work or attend schoolFree text: Mild uri symptoms. Positive for Covid 5/25/2022 symptoms only last three days: nasal congestion, no fever, no cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-15
- 2022-10-14
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
| 4 | 2022-04-15 | Moderna | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Single shotty cervical node on same side as injection
Systemic reaction (other): Single cervical node on same side as injection (1cm)
Release 9 — 6 months, dose 2
Symptoms: Covid negative viral URI
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Mild lymphadenopathy in ipsilateral Scilla, no different from previous Covid vaccine injections
Systemic reaction (other): Mild ipsilateral axillary adenopathy
Systemic reaction (other): Previously described adeopathy resolving
Release 11 — day 42, dose 4
Symptoms: Mild uri symptoms. Positive for Covid 5/25/2022 symptoms only last three days: nasal congestion, no fever, no cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Viral upper respiratory tract infection | ✓ | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release